Skip to main content
. 2017 Jul 23;6(7):e005657. doi: 10.1161/JAHA.117.005657

Figure 5.

Figure 5

Net clinical benefit, adjusted for the mortality risk, of OAC vs no OAC (antiplatelet therapy only or no antithrombotic drug) according to different age strata, including ischemic stroke, systemic embolism, myocardial infarction, hemorrhagic stroke, and major bleeding as outcome measures. OAC indicates oral anticoagulant therapy.